A New Must-Read Blog: Cancerous Capers

“I'm Jamie Ross.

I'm twenty, and I was an English student until last August when my doctor threw a giant cancerous spanner in the works. This blog tracks my little fracas with Hodgkin's Lymphoma and is a reading experience that will make you laugh, cry and possibly physically sick as I mention my testicles more times than social convention deems acceptable.”

Now that’s a blog. How can anyone resist following his adventures? http://cancerouscapers.blogspot.com/

For another teaser….”They led with the stomach-turning headline of ‘Blog of Courage’ and tediously droned on about what a “brave teen” I am. I’m astonished that it didn't come with a huge cut-outable photo of my smiling, pale face for housewives across the country to hold their shriekingly oversentimental candlelit vigils next to - most likely with ‘Kinross Princess’ emblazoned in massive lettering across it. There seems to be some insane belief amongst idiot headline writers that having cancer instantly makes you brave. It doesn’t. It makes you bald, podgy, ill and bored - ‘Blog of Sheer Tedium’ would have been a far more appropriate headline. I had to wake up my Mum at 4am last week specifically so she could remove a below-average sized spider from my room - that‘s your sodding megahero, The Sun.”

Or catch him on twitter @JamieRoss7

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap